课题基金 / 基金详情

Studies on the signal transduction passways through IL-12 receptor

Studies on the signal transduction passways through IL-12 receptor
IL-12受体信号转导通路的研究
批准号:
14570285
负责人:
YOSHIMOTO Takayuki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

YOSHIMOTO Takayuki的其他基金

相似基金

相关文献

中文摘要
翻译
通过酵母双杂交技术筛选出小鼠鞘氨醇激酶2(SPHK 2),并鉴定其为与小鼠IL-12 R β1胞浆区相关的分子。对SPHK 2的各种突变体的分析表明,SPHK 2中富含脯氨酸的区域可能与IL-12 R β1的结合有关,而IL-12 R β1胞浆区的羧基端和Box II区域可能与SPHK 2的结合有关。野生型SPHK 2在T细胞杂交瘤中的瞬时表达增强了IL-12诱导的STAT 4介导的转录激活。显性阴性SPHK 2在Th 1细胞克隆中的异位表达可显著降低IL-12诱导的IFN-γ产生,而野生型SPHK 2则可增强IFN-γ产生,而对IL-12诱导的细胞增殖影响甚微。当使用逆转录病毒表达系统在活化的原代T细胞中表达显性阴性SPHK 2时,观察到IL-12诱导的IFN-γ产生的类似减少。这些结果表明SPHK 2与IL-12 R β1胞浆区结合,可能在调节IL-12信号转导中发挥作用。我们还研究了JAK/STAT信号分子激活的IL-27和STAT 1在IL-27介导的反应中的作用,使用STAT 1缺陷小鼠。我们发现IL-27激活了初始CD 4 + T细胞中的JAK 1、-2 TYK 2、STAT 1、-2、-3和-5。在STAT 1缺陷型和野生型幼稚CD 4 + T细胞之间观察到对IL-27的相当的增殖反应。相比之下,IL-27不能诱导T-bet和IL-12 R β2的表达,并且IL-27和IL-12的协同IFN-γ产生也在STAT 1缺陷的幼稚CD 4 + T细胞中受损。这些结果表明,IL-27激活初始CD 4 + T细胞中的JAK 1,-2,TYK 2,STAT 1,-2,-3和-5,并且STAT 1在IL-27诱导的T-bet和IL-12 R β2表达中起不可或缺的作用,但不参与增殖。
英文摘要
We performed a yeast two-hybrid screening and identified the mouse sphingosine kinase 2 (SPHK2) as a molecule associating with mouse IL-12Rβ1 cytoplasmic region. Analyses on various mutants of each molecule revealed that the region including proline-rich domain in SPHK2 is likely to be responsible for the binding to IL-12Rβ1, while the regions including the carboxyl terminus and Box II in IL-12Rβ1 cytoplasmic region appear to be involved in the binding to SPHK2. Transient expression of wild-type SPHK2 in T cell hybridoma augmented IL-12-induced STAT4-mediated transcriptional activation. Ectopic expression of dominant-negative SPHK2 in Th1 cell clone significantly reduced IL-12-induced IFN-γ production, while that of wild-type SPHK2 enhanced it. In contrast, the expression minimally affected IL-12-induced proliferation. Similar decrease in IL-12-induced IFN-γ production was observed when dominant-negative SPHK2 was expressed in activated primary T cells by using a retroviral expression system. These results suggest that SPHK2 associates with IL-12Rβ1 cytoplasmic region and is likely to play a role in modulating IL-12 signaling. We also investigated the JAK/STAT signaling molecules activated by IL-27 and the role of STAT1 in IL-27-mediated responses using STAT1-deficient mice. We found that IL-27 activated JAK1, -2 TYK2, STAT1,-2,-3, and -5 in naive CD4+ T cells. Comparable proliferative response to IL-27 was observed between STAT1-deficient and wild-type naive CD4+ T cells. In contrast, IL-27 failed to induce T-bet arid IL-12Rβ2 expression, and synergistic IFN-γ production by IL-27 and IL-12 was also impaired in STAT1-deficient naive CD4+ T cells. These results suggest that IL-27 activates JAK1,-2, TYK2, STAT1, -2,-3, and -5 in naive CD4+ T cells and that STAT1 plays an indispensable role in IL-27-induced T-bet and IL-12Rβ2 expression but not proliferation.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
M.Shimizu et al.: "Modification of tumor cells with Fas(CD95)antigen gene and Fas ligand(CD95L)gene transfection by electroporation for immunotherapy of cancer."Mol.Biotechnol.. 25. 79-87 (2003)
M.Shimizu 等人:“通过电穿孔用 Fas(CD95) 抗原基因和 Fas 配体 (CD95L) 基因转染对肿瘤细胞进行修饰,用于癌症的免疫治疗。”Mol.Biotechnol.. 25. 79-87 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Hisada: "Potent anti-tumor activity of interleukin-27."Cancer Res.. 64. 1152-1156
M.Hisada:“白细胞介素 27 具有有效的抗肿瘤活性。”癌症研究 64. 1152-1156
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Suzuki: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)
H.Suzuki:“逆转录病毒介导的 TRAIL 转导和化疗药物协同诱导肉瘤和骨髓瘤细胞的凋亡细胞死亡。”Anticancer Res.. 23. 3247-3254 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H.Suzuki et al.: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co- operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)
H.Suzuki 等人:“逆转录病毒介导的 TRAIL 转导和化疗药物协同诱导肉瘤和骨髓瘤细胞中的细胞凋亡。”Anticancer Res.. 23. 3247-3254 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 23 条
    Study on the regulation of immune responses by a novel IL-6/IL-12 family cytokine
    • 批准号:
      24370058
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2012
    • 负责人:
      YOSHIMOTO Takayuki
    • 依托单位:
    Immune regulation by the IL-6/IL-12 family cytokines
    • 批准号:
      20370049
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $13.23万
    • 财政年份:
      2008
    • 负责人:
      YOSHIMOTO Takayuki
    • 依托单位:
    Construction of the Remote Education Network for Exchange of Musical Culture
    • 批准号:
      12680259
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2000
    • 负责人:
      YOSHIMOTO Takayuki
    • 依托单位:
    Study on the role of IL-12 in protective immunity against infection
    • 批准号:
      09044265
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $2.5万
    • 财政年份:
      1997
    • 负责人:
      YOSHIMOTO Takayuki
    • 依托单位:
    海外基金